SOCS1 and neoplasm: Since SOCS1 is also not adequately expressed in BCC and SCC lesions, it would be interesting to evaluate the potential anti-tumor effects of KIR-SOCS1 mimetic peptides, such as PS5, in BCC and SCC lines.